SEB Asset Management AB »

Jazz Pharmaceuticals shares owned by SEB Asset Management AB

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by SEB Asset Management AB from 13F filings

Historical chart of SEB Asset Management AB investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by SEB Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by SEB Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.8M 46k 189.05

More positions owned by SEB Asset Management AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Astrazeneca Ord (AZN)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Citigroup Com New (C)
Tesla Motors (TSLA)

View all positions for SEB Asset Management AB

Top funds holding Jazz Pharmaceuticals

Vanguard Group
BlackRock
Vanguard Portfolio Management
Capital World Investors
Vanguard Capital Management
LSV Asset Management
Franklin Resources
Dimensional Fund Advisors
State Street Corporation
EcoR1 Capital
Bank of New York Mellon
Hanna Zanoni
Ameriprise Financial
Citadel Advisors
AQR Capital Management

View all funds holding Jazz Pharmaceuticals